{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nCurrent evidence suggests that MIS18A‐AS1, a long non‐coding RNA transcribed antisense to the MIS18A gene, may play a regulatory role in cell proliferation. Although its functions have not been fully elucidated, MIS18A‐AS1 is hypothesized to modulate the expression of genes critical for cell cycle progression and centromere assembly—processes essential for proper cellular division. This regulatory activity might be especially relevant in pancreatic β‐cells, where maintaining an adequate functional mass is crucial to overcoming the deficits observed in diabetes mellitus."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn the context of pancreatic islet biology, the study highlighted the role of ST5 in activating Ras/Erk signaling in response to EGF, a pathway pivotal for enhanced β‐cell proliferation during physiological states like pregnancy. Although the primary focus of the study was on the overexpression of ST5 to stimulate β‐cell expansion, the identification of non‐coding transcripts such as MIS18A‐AS1 within this regulatory network raises the possibility that MIS18A‐AS1 might intersect with these mitogenic pathways. Its potential impact on modulating gene expression could represent an additional layer of control over β‐cell replication, thus contributing indirectly to improved cell mass in diabetes."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nThe findings underscore the importance of exploring long non‐coding RNAs like MIS18A‐AS1 as modulators of cell proliferation and function. Further investigation into its molecular mechanisms may reveal novel regulatory interactions with key signaling molecules such as ST5 and the downstream Ras/Erk cascade. Such insights could eventually lead to innovative therapeutic strategies designed to enhance β‐cell regeneration, offering potential benefits for both Type I and Type II diabetes mellitus."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": ""}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Kristy Ou, Jia Zhang, Yang Jiao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Overexpression of ST5, an activator of Ras, has no effect on β-cell proliferation in adult mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Metab (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molmet.2018.03.009"}], "href": "https://doi.org/10.1016/j.molmet.2018.03.009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29650351"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29650351"}]}]}]}